Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
233.8 USD | -0.89% | -1.71% | +6.35% |
Business Summary
Number of employees: 1,168
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 1,936 | 100.0 % | 2,328 | 100.0 % | +20.20% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.6
%
| 1,814 | 93.7 % | 2,202 | 94.6 % | +21.39% |
Rest of World
5.4
%
| 122 | 6.3 % | 125 | 5.4 % | +2.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 96-06-25 | |
President | 52 | 11-03-31 | |
James Edgemond
DFI | Director of Finance/CFO | 56 | 12-12-31 |
Dewey Steadman
IRC | Investor Relations Contact | - | - |
Paul Mahon
LAW | General Counsel | 60 | 96-06-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 76 | 01-12-31 |
Chief Executive Officer | 69 | 96-06-25 | |
Tommy Thompson
BRD | Director/Board Member | 81 | 09-12-31 |
Judy Olian
BRD | Director/Board Member | 72 | 15-06-25 |
Katherine Klein
BRD | Director/Board Member | 67 | 14-11-10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01-12-31 |
Director/Board Member | 60 | 02-10-23 | |
Director/Board Member | 61 | 02-12-31 | |
Richard Giltner
BRD | Director/Board Member | 60 | 09-04-28 |
Nilda Mesa
BRD | Director/Board Member | 64 | 18-10-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,677,761 | 46,249,429 ( 62.77 %) | 26,619,216 ( 36.13 %) | 62.77 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CELULARITY INC. 3.66% | 796,885 | 3.66% | 4,167,709 $ |
CLENE INC. 2.23% | 2,869,517 | 2.23% | 1,219,545 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.35% | 11B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
-16.98% | 10.07B |
- Stock Market
- Equities
- UTHR Stock
- Company United Therapeutics Corporation